BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Month: September 2024

1 post
CEL-SCI Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer

Biotech NewsCEL-SCI’s Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer

  • BioTech Health X
  • September 16, 2024
CEL-SCI Corporation (NYSE American: CVM) has announced new breakthrough data from its Phase 3 trial of Multikine®, an…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Lakeside Holding (LSH) Deepens Roots in Pharmaceutical Logistics with $1.5M Sinopharm Agreement
  • NeuBase (NBSE)’s PATrOL™ Platform: The Future of RNA-Targeted Therapies
  • Analysts Maintain Optimism as Lexicon Pharmaceuticals (LXRX) Focuses on Long-Term Growth
  • Mersana (MRSN) Leverages Partnerships with Johnson & Johnson (JNJ), Merck (MRK) to Advance ADCs
  • Aditxt (ADTX)’s $32.7M Investment Fuels Growth in the $84B Autoimmune Disease Market
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • December 17, 2024
    Lakeside Holding (LSH) Deepens Roots in Pharmaceutical Logistics with $1.5M Sinopharm Agreement
    • December 15, 2024
    NeuBase (NBSE)’s PATrOL™ Platform: The Future of RNA-Targeted Therapies
    • December 15, 2024
    Analysts Maintain Optimism as Lexicon Pharmaceuticals (LXRX) Focuses on Long-Term Growth
    • December 14, 2024
    Mersana (MRSN) Leverages Partnerships with Johnson & Johnson (JNJ), Merck (MRK) to Advance ADCs
    • December 12, 2024
    Aditxt (ADTX)’s $32.7M Investment Fuels Growth in the $84B Autoimmune Disease Market
Recent Posts
  • COVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive - Virology Experts Weigh In
    Corvus (CRVS) Shows Financial Resilience with $41.7M Cash and Strategic R&D Investments
    • December 7, 2024
  • Avidity Biosciences (RNA): Strengthened by $1.6 Billion Cash Position and Strategic Partnerships
    • December 6, 2024
  • The Future of Genomics: GeneDx (WGS) Achieves Profitability & Expands Market Reach
    The Future of Genomics: GeneDx (WGS) Achieves Profitability & Expands Market Reach
    • December 5, 2024
Categories
  • BioTech CEO Interviews (5)
  • Biotech Info (1)
  • Biotech News (96)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top